KND Related Analyst Ratings
-
Susquehanna Upgrades Kindred Healthcare (KND) to Positive
-
Citi Starts Kindred Healthcare (KND) at Neutral
-
UPDATE: UBS Starts Kindred Healthcare (KND) at Neutral; Well Diversified, But Uncertainty Looms
-
Sidoti Starts Kindred Healthcare (KND) at Buy
-
Stifel Nicolaus Starts Kindred Healthcare (KND) at Hold
-
Avondale Partners Upgrades Kindred Healthcare (KND) to Market Outperform
-
Jefferies Upgrades Kindred Healthcare (KND) to Buy
-
Susquehanna Downgrades Kindred Healthcare (KND) to Neutral
-
Wells Fargo Downgrades Kindred Healthcare (KND) to Market Perform; CMS Rule Creates Overhang
-
Avondale Partners Downgrades Kindred Healthcare (KND) to Market Perform
-
UPDATE - UBS Downgraded Ventas (VTR) to Neutral; Moving To Sidelines on Likely Lease Overhang
-
BofA/Merrill Lynch Downgrades Kindred Healthcare (KND) to Underperform
-
Barclays on Health Care Facilities: Feinstein's Weekly Insights & Observations
-
Wells Fargo Upgrades Kindred Healthcare (KND) to Outperform; Expects To Mitigate Substantial Portion Of SNF Cuts
-
Jefferies Cuts Price Target on Kindred Healthcare (KND)
-
RBC Capital Downgrades Kindred Healthcare (KND) to Sector Perform
-
BB&T Capital Downgrades Kindred Healthcare (KND) to Hold
-
Kindred (KND), Skilled (SKH) and Sun Healthcare (SUNH) Expected To See Pressure on CMS Rate Cut
-
Jefferies Downgrades Kindred Healthcare (KND) to Hold
-
Barclays Maintains an 'Overweight' on Kindred Healthcare (KND); Cluster Market Expansions
-
Barclays on Health Care Facilities: Feinstein's Weekly Insights & Observations
-
Barclays on U.S. Health Care Facilities: Las Vegas Meeting Review: UHS, HLS & KND
-
FBR Capital on Healthcare Services 1Q11 Earnings Preview
-
Barclays Maintains an 'Overweight' on Kindred Healthcare (KND); Thoughts on Kindred's Home Health Acquisition
-
Barclays Maintains an 'Equalweight' on PharMerica (PMC); December Quarter Review - After the Call
-
UPDATE - Barclays Upgraded Kindred Healthcare (KND) to Overweight with Accretion from RehabCare Group Deal
-
JPMorgan Upgrades Kindred Healthcare (KND) to Overweight
-
Jefferies Raises Price Target on Kindred Healthcare (KND), Maintains Buy Rating
-
Barclays Upgrades Kindred Healthcare (KND) to Overweight
-
BofA/Merrill Lynch Upgrades Kindred Healthcare (KND) to Neutral
-
Susquehanna Upgrades Kindred Healthcare (KND) to Positive
-
FBR Capital Maintains a 'Market Perform' on Kindred Healthcare (KND); Announces Acquisition of RehabCare Group
-
Jefferies Raises Price Target on Kindred Healthcare (KND), Maintains Buy Rating
-
RBC Capital Upgrades Kindred Healthcare (KND) to Outperform
-
Barclays maintains an 'Equalweight' on Skilled Healthcare (SKH); Strong Guidance Far Ahead of Expectations Confirming Favorable Medicare Rates in '11
-
Barclays maintains an 'Equalweight' on Skilled Healthcare Group (SKH); Better Than Expected Guidance Coming?
-
Barclays Maintains an 'Equalweight' on Kindred Healthcare (KND); Initial 2011 Guidance - RUG-IV Better than Expected
-
FBR Capital Maintains a 'Market Perform' on Kindred Healthcare (KND); 2011 Guidance Implies Solid Growth
-
FBR Capital: Healthcare Services 2011 Outlook
-
Jefferies Upgrades Kindred Healthcare (KND) to Buy, Price Target $21
-
BB&T Capital Upgrades Kindred Healthcare (KND) to Buy
-
FBR Capital Launching Coverage of Post–Acute Care Services: How About a Bowl of Alphabet Soup?
-
Barclays Maintains an 'Equalweight' on Kindred Healthcare (KND); Lowers PT
-
Stifel Nicolaus Upgrades Kindred Healthcare (KND) to Buy
-
Wells Fargo Upgrades Kindred Healthcare (KND) to Market Perform; Valuation and Sentiment
-
Susquehanna Initiates Coverage on PharMerica Corp (PMC) with a Neutral
-
BofA/Merrill Lynch Downgrades Kindred Healthcare (KND) to Underperform
-
Susquehanna Initiates Coverage on Kindred Healthcare (KND) with a Neutral
-
Susquehanna Starts Healthcare Facilities Stocks: ODSY, LNCR, HLS at Positive, AHS, CCRN at Negative
-
RBC Capital Downgrades Kindred Healthcare (KND) to Sector Perform
Back to KND Stock Lookup
